Home
Search
Agriculture & Environment

Addressing Climate Change

There are more than 5 trillion pieces of plastic floating in our oceans. The U.S. transportation sector leads all other sectors in greenhouse gas emissions. Diseases that thrive in hot weather are killing important staple crops. Our reliance on products derived from fossil fuels is harming our planet.

Climate change is real but through biotechnology, we can meet these challenges head-on by making the same reliable plastics, foods, and fuels with less environmental impact.

Dr Michelle Climate
Biotech Solutions for Climate Report
Biotech Solutions for Climate Executive Summary
More on BIO's Global Climate Leadership
Latest from BIO's Experts...
GMOS and Gene Editing—Nothing to Be Afraid Of
GMOS and Gene Editing—Nothing to Be Afraid Of
Learn more
Escaping the Food Allergy Prison
Escaping the Food Allergy Prison
Learn more
Car Free Day
Car-Free Day: Could Biotech Make It a Thing of the Past?
Learn more
Bananas
Improving Food Systems: The Case of the Banana
Learn more
roots Trees Alone Can’t Solve Our Climate Issues
Trees Alone Can’t Solve Our Climate Issues
Learn more
Press Releases
Browse all Press Releases
Announcement of PDUFA Agreement in Congress Supports Biomedical Innovation, Helps Patients
September 22, 2022
Biotechnology Industry Organization (BIO) President and CEO, Dr. Michelle McMurry-Heath, released the following statement following the announcement that Congress reached an agreement on the Prescription Drug User Fee Act (PDUFA): “For 30 years, PDUFA has been absolutely critical to…
Biden's Executive Order to Advance Biotechnology, Biomanufacturing Prioritizes Science to Solve Global Challenges
September 13, 2022
Dr. Michelle McMurry-Heath, president & CEO of the Biotechnology Innovation Organization, released the following statement in response to the Biden Administration’s “Advancing Biotechnology and Biomanufacturing” Executive Order: “BIO welcomes the Biden Administration’s directives to…
BIO Calls for Actions to Bolster IRA's Climate Investments by Advancing Biotech
September 8, 2022
As the Biden Administration begins implementation of the Inflation Reduction Act, the Biotechnology Innovation Organization today called on the administration to take additional steps to foster the development and deployment of pioneering technologies that are critical to meeting the nation’s…
Good Day BIO Newsletter
Subscribe to GoodDay BIO

Receive the best resource for the biotech industry with Good Day BIO, the only daily newsletter at the intersection of biotech, politics and policy. 

Subscribe

A Timeline of Modernizing Food and Farm Biotech Laws...

plants
2019: USDA Announces SECURE Rule

To provide transparency to consumers, BIO advocates for the agency to require developers to notify them when new plants are brought to market,
Cabinet
2019: Executive Order to Modernize Biotech Framework

President Trump directs USDA, EPA, and FDA to align existing biotech regulations with actual risk and to grow pubic confidence in biotech to benefit our food, health, and planet.
Trump Rural
2017: Trump Administration Establishes Rural Prosperity Task Force

The task force includes biotechnology as part of its recommendations to the government on how to strengthen rural economies.
Obama produce
2017: Obama Administration Updates Biotech Laws

To keep up with 21st-century innovations USDA and FDA begin updating definitions and enforcement of biotech plants and animals. 
obama flag
2012: National Bioeconomy Blueprint Unveiled

The blueprint is a comprehensive vision to strengthen America's economy through technology and science, and spotlights agricultural biotechnology.
Letters, Comments & Testimony
Browse all Letters, Comments & Testimony
BIO Joins Letter to Congress Urging for Expeditious Confirmation of Doug McKalip as Chief Agricultural Negotiator at USTR
September 21, 2022
On behalf of the broad and diverse stakeholders in American Agriculture we represent, we urge you to work with your colleagues to expeditiously confirm Doug  McKalip as Chief Agricultural Negotiator at the Office of the U.S. Trade Representative (USTR).
BIO Comments on FDA Guidance for Risk Management Plans to Mitigate the Potential for Drug Shortages
August 31, 2022
Today, BIO submitted comments in response to the FDA’s recent draft guidance on the development, maintenance, and implementation of Risk Management Plans (RMPs). While the comment letter expressed broad support for the systematic approach for establishing risk management plans (RMPs) laid out in…
BIO Comments on WHO White Paper: Regulation of Cell and Gene Therapy Products
September 9, 2022
Today, BIO submitted comments to the World Health Organization (WHO) regarding its revised, draft white paper on the regulation of Cell and Gene Therapy Products (CGTPs). As stated previously, BIO emphasized that this paper represents a major milestone and will be the first global regulatory…